Advertisements



Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update

LA JOLLA, Calif., April 14, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL), a cl.....»»

Category: earningsSource: benzingaApr 14th, 2020

Artelo Biosciences Reports First Quarter Fiscal Year 2020 Financial Results and Provides Business Update

LA JOLLA,.....»»

Category: earningsSource: benzingaJan 14th, 2020

Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update

LA JOLLA, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial and .....»»

Category: earningsSource: benzingaNov 25th, 2019

Pacira BioSciences Reports First Quarter 2020 Financial Results and Business Update

-- Total revenues increased 16 percent over prior year first quarter ---- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., May 07, 2020.....»»

Category: earningsSource: benzingaMay 7th, 2020

Conn"s, Inc. Reports Fourth Quarter Fiscal Year 2020 Financial Results And Provides Business Update Related to COVID-19

THE WOODLANDS, Texas, April 14, 2020 (GLOBE N.....»»

Category: earningsSource: benzingaApr 14th, 2020

Canada House Wellness Group Reports Third Quarter Fiscal Year 2020 Results and Provides Business Update Regarding COVID-19

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, March 25, 2020 /CNW/ - Canada House Wellness Group Inc. (CSE:CHV) ("Canada House" or the "Company") is pleased to report its financial results f.....»»

Category: earningsSource: benzingaMar 25th, 2020

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update

-Presented initial clinical data for lead allogeneic CAR T program PBCAR0191 for the treatment of NHL and B-ALL- -Implemented amendment to PBCAR0191 Phase 1/2a trial focused on optimizing clinical activity,.....»»

Category: earningsSource: benzingaMar 10th, 2020

Outlook Therapeutics Provides Business Update and Reports Financial Results for the First Quarter of Fiscal Year 2020

CRANBURY, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the "Company"), a late clinical-stage biopharmaceutical comp.....»»

Category: earningsSource: benzingaFeb 14th, 2020

Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update

Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaMar 13th, 2019

4Front Announces Fiscal Year 2019 Fourth Quarter and Year End Financial Results, Preliminary First Quarter 2020 Results and Business Update

Q4 2019 Systemwide Pro Forma Sales of $17.5m, an increase of 525% over Q4 2018. 2019 Full Year Systemwide Pro Forma Sales for 2019 of $63.5m, an increase of 786% over full year 2018. Q1 2020 Systemwide Pro Forma Sales of $23.8m,.....»»

Category: earningsSource: benzingaJun 15th, 2020

4Front Announces Fiscal Year 2019 Fourth Quarter and Year End Financial Results, Preliminary First Quarter 2020 Results and Business Update

Q4 2019 Systemwide Pro Forma Sales of $17.5m, an increase of 525% over Q4 2018. 2019 Full Year Systemwide Pro Forma Sales for 2019 of $63.5m, an increase of 786% over full year 2018. Q1 2020 Systemwide Pro Forma Sales of $23.8m, an .....»»

Category: earningsSource: benzingaJun 15th, 2020

FuelCell Energy Reports Results for the Second Quarter of Fiscal 2020 and Provides Business Update

Second Quarter Fiscal 2020 Highlights (All comparisons year-over-year unless otherw.....»»

Category: earningsSource: benzingaJun 12th, 2020

Replimune Reports Fiscal Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

WOBURN, Mass., June 03, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ:REPL), a biotechnology company developing a series o.....»»

Category: earningsSource: benzingaJun 3rd, 2020

Canopy Growth Reports Full Year and 4th Quarter Fiscal 2020 Financial Results; Provides Strategic Review Update

Canopy Growth Reports Full Year and 4th Quarter Fiscal 2020 Financial Results; Provides Strategic Review Update.....»»

Category: earningsSource: benzingaMay 29th, 2020

Canopy Growth Reports Full Year and 4th Quarter Fiscal 2020 Financial Results; Provides Strategic Review Update

Canopy Growth Reports Full Year and 4th Quarter Fiscal 2020 Financial Results; Provides Strategic Review Update.....»»

Category: earningsSource: benzingaMay 29th, 2020

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights

CRANBURY, N.J., May 12, 2020 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE:PT.....»»

Category: earningsSource: benzingaMay 12th, 2020

IDEAYA Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., May 12, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics.....»»

Category: earningsSource: benzingaMay 12th, 2020

Lightspeed Provides Business Update

Announces Fourth Fiscal Quarter and Full Year 2020 Financial Results Conference Call MONTREAL, April 8, 2020 /PRNewswire/ - Lightspeed POS Inc. ("Lightspeed" or the "Company") (TSX: LSPD), a leading cloud-based com.....»»

Category: earningsSource: benzingaApr 8th, 2020

IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., March 24, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using .....»»

Category: earningsSource: benzingaMar 24th, 2020

Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update

LEXINGTON, Mass., March 19, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focus.....»»

Category: earningsSource: benzingaMar 19th, 2020